

The game of venture capital involves founders selling equity in their companies for cash. Pretty simple, when you think about it.
Except in recent years, there's been a substantial uptick in founders selling (the promise of) equity for cash through convertible instruments like SAFEs and Convertible Notes.
For young companies, these instruments make a lot of sense because deciding on a valuation for a 6-month old startup is a futile exercise. Let's just get this founder some capital to have a go at it and hopefully a future investor will price our equity later on.
But lots and lots of startups that already have real valuations are using these convertibles.
…but why?
Could be that convertibles (especially SAFEs) are easier to get done quickly so both parties turn to them when time is of the essence.
Could be that convertibles make it slightly easier to fund companies who need a bridge without calling into question the current valuation.
Could be…lots of things.
But there's no denying that the introduction of convertible financing in the middle of venture rounds has made the whole thing messier.
Onwards!
Subscribe here if you're new to the Data Minute. Forwarding encouraged!
Cheers,
Peter Walker
Carta Insights
DISCLOSURE: This communication is on behalf of eShares, Inc. dba Carta, Inc. ("Carta"). This communication is for informational purposes only, and contains general information only. Carta is not, by means of this communication, rendering accounting, business, financial, investment, legal, tax, or other professional advice or services. This publication is not a substitute for such professional advice or services nor should it be used as a basis for any decision or action that may affect your business or interests. Before making any decision or taking any action that may affect your business or interests, you should consult a qualified professional advisor. This communication is not intended as a recommendation, offer or solicitation for the purchase or sale of any security. Carta does not assume any liability for reliance on the information provided herein. © 2026 Carta. All rights reserved. Reproduction prohibited.



